Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico

South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...

S.Korea's EuBiologics to receive support from Gates Foundation

S.Korea's EuBiologics to receive support from Gates Foundation

South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...

Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm signs contract to supply medicines to Saudi Arabia

Korea United Pharm. Inc. announced on Monday that it signed a contract to supply nine types of medicines, including 11 anticancer drugs, to Saudi ph...

SK Biopharm holds sales meeting for marketing Cenobamate in US

SK Biopharm holds sales meeting for marketing Cenobamate in US

On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...

HK inno.N's GERD drug K-CAB gets approval in Mexico

HK inno.N's GERD drug K-CAB gets approval in Mexico

South Korea's biohealth company HK inno.N said on Tuesday that its gastroesophageal reflux disease (GERD) treatment K-CAB (active ingredient: tegopr...

LG Chem builds S.Korea's first plant for clinical trials

LG Chem builds S.Korea's first plant for clinical trials

LG Chem Ltd. has built South Korea’s first pharmaceutical plant dedicated to clinical trials, which the company expects to speed up its medici...

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma, Sanofi to jointly market Plavix

GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...

Daewoong Pharma wins permission from Singapore for Nabota

Daewoong Pharma wins permission from Singapore for Nabota

South Korea's drug development company Daewoong Pharmaceutical said on Thursday that it received on Jan. 20 product approval for its botulinum toxin...

Hanmi Pharmaceutical reports record-high revenue in 2022

Hanmi Pharmaceutical reports record-high revenue in 2022

South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...

S.Korea's Boryung receives EU GMP certification

S.Korea's Boryung receives EU GMP certification

South Korean pharmaceutical company Boryung announced that its production facility for anti-cancer injections in Yesan, South Chungcheong Province, ...

Chong Kun Dang, Synaffix ink deal to introduce ADC technology

Chong Kun Dang, Synaffix ink deal to introduce ADC technology

Chong Kun Dang Pharmaceutical Corp. said on Monday that it has signed a contract with Dutch biotechnology firm Synaffix B.V for the use of antibody-...

Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong receives approval for its GERD drug Fexuclue in Ecuador

Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...

Prestige Biopharma submits clinical trial plan in Australia

Prestige Biopharma submits clinical trial plan in Australia

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US,  has applied to the Australian clini...

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

Hanmi's Rolvedon set to post $10 mn in Q4 net sales in US

South Korean drugmaker Hanmi Pharmaceutical Co.’s neutropenia agent, Rolvedon (eflapegrastim-xnst), is forecast to achieve about $10 million i...

Korea's InCerebro to leverage AI to identify drug candidates

Korea's InCerebro to leverage AI to identify drug candidates

South Korean AI-based drug developer InCerebro aims to identify potential drug candidates using molecular modeling technology, according to its CEO ...

S.Korea's Daewoong Pharmaceutical to export tech to British company

S.Korea's Daewoong Pharmaceutical to export tech to British company

South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...

JW Pharma to put AI into new drug ingredient development

JW Pharma to put AI into new drug ingredient development

South Korea's drug developer JW Pharmaceutical is expanding the scope of its artificial intelligence (AI) uses from new drug research to the develop...

S.Korea, Japan compete in gastroesophageal reflux drug market

S.Korea, Japan compete in gastroesophageal reflux drug market

South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

Bridge Biotherapeutics, Pinotbio develop lung cancer treatment

South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...

Inventage Lab launches clinical trials for addiction treatment in Australia

Inventage Lab launches clinical trials for addiction treatment in Australia

South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...

HK inno.N's K-CAB to get insurance benefits in China

HK inno.N's K-CAB to get insurance benefits in China

South Korea’s 30th novel medicine K-CAB Tab (active ingredient: tegoprazan), a gastroesophageal reflux disease (GERD) treatment of HK inno.N, ...

ST Pharm exports $14.6 mn worth of drug ingredients to Europe

ST Pharm exports $14.6 mn worth of drug ingredients to Europe

ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...

GC Biopharma's Sanfilippo treatment eligible for FDA priority review

GC Biopharma's Sanfilippo treatment eligible for FDA priority review

GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...

Daewoong accelerates investment in CDMO business

Daewoong accelerates investment in CDMO business

Daewoong, the holding company of South Korea's pharmaceutical-oriented Daewoong Group, is speeding up its pace to beef up its contract development a...

JVM to sell fully automated drug inspection machines in US

JVM to sell fully automated drug inspection machines in US

Hanmi Pharmaceutical Co. said on Monday that it had signed an agreement with Euclid Medical Products, a company specializing in manufacturing drug d...

Celltrion develops oral antibody drug with US bio company

Celltrion develops oral antibody drug with US bio company

South Korea's biopharmaceutical company Celltrion Inc. on Monday said it signed an R&D contract with US-based Rani Therapeutics on RT-111, an or...

Daewoong, Onchorus to undertake research on mRNA anticancer drugs

Daewoong, Onchorus to undertake research on mRNA anticancer drugs

Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

HLB confirms ophthalmic disease treatment in phase 3 clinical trials

South Korea’s biomedicine startup HLB Therapeutics Co. said on Monday that its Neurotrophic Keratopathy (NK) treatment RGN-259 proved effectiv...

Daewoong Pharma, Neurolive to jointly develop new antidepressant drug

Daewoong Pharma, Neurolive to jointly develop new antidepressant drug

South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...

KOICA donates Celltrion's Herzuma to Ukraine

KOICA donates Celltrion's Herzuma to Ukraine

Celltrion Healthcare Co. said on Monday that Herzuma (ingredient name: Trastuzumab) was dispatched to patients in Ukraine by the Korea International...

Shinsegae chair likely to head Asian arm of pro-Trump Rockbridge S.Korea’s leading ERP player Douzone Bizon up for sale; EQT Partners in talks MSCI maintains S.Korea’s emerging-market status; level playing field required GEPS taps former KB Asset chief risk officer as new CIO Affinity Equity nets $220 mn from block sale of Shinhan Financial